Spark Therapeutics (ONCE) IPO Opens Up 96%
Get Alerts ONCE Hot Sheet
Join SI Premium – FREE
Today's IPO for Spark Therapeutics (NASDAQ: ONCE) opened for trading at $45.10 after pricing 7,000,000 shares of common stock at a public offering price of $23.00 per share, above the expected $19-$21 range.
J.P. Morgan Securities LLC and Credit Suisse Securities (USA) LLC are acting as lead book-running managers for the offering. Cowen and Company, LLC is acting as lead manager and Sanford C. Bernstein & Co., LLC is acting as co-manager.
Spark is a late clinical-stage gene therapy company seeking to develop one-time, life-altering treatments for debilitating genetic diseases, with an initial focus on treating rare diseases. Spark's most advanced product candidate, SPK-RPE65, which has received both breakthrough therapy and orphan product designation, is in a fully-enrolled pivotal Phase 3 clinical trial for the treatment of a rare blinding condition. Spark also has product candidates in development for the treatment of additional blinding conditions, hematologic disorders and neurodegenerative diseases.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fisker (FSR) files form 10-K, sees more job cuts, reiterates going concern doubts
- SunPower (SPWR) determined prior financial statements should no longer be relied upon
- Pioneer Power (PPSI) Receives Nasdaq Non-compliance Notice
Create E-mail Alert Related Categories
Hot IPOs, IPOsRelated Entities
Credit Suisse, JPMorgan, Sanford C. Bernstein, Cowen & Co, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!